Komori
PHC Holdings (6523) · RiskFirst stated

Impact on financial results from an inappropriate incident involving the LSIM business

First written in FY2026. . Latest entry: FY2026.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Business performance and order impact from an inappropriate incident in the LSIM businessA theme 1 companies write about · 1 as a headwind · 0 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2026First statedAnnual report

    「The LSIM business reported higher revenue, as it was able to contain the impact of the improper incident more effectively than anticipated, in addition to increased testing revenue in the genetic testing field, which is being pursued as a growth initiative. The CRO business reported lower revenue due to a decline in clinical trial orders resulting from the impact of the improper incident at LSIM and other factors.」

    The improper incident at LSIM was explicitly identified for the first time, as an issue whose impact was being contained in the LSIM business and as a factor behind the decline in clinical trial orders in the CRO business. The disclosure does not describe the details or financial impact of the incident.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for PHC Holdings yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Impact on financial results from an inappropriate incident involving the LSIM business | PHC Holdings Corporation (6523) | Komori